Continuum Advisory’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Sell |
8,589
-1,554
| -15% | -$362K | 0.2% | 102 |
|
|
2025
Q4 | $2.1M | Buy |
10,143
+280
| +3% | +$55.4K | 0.21% | 106 |
|
|
2025
Q3 | $1.83M | Buy |
9,863
+253
| +3% | +$43.3K | 0.19% | 111 |
|
|
2025
Q2 | $1.47M | Buy |
9,610
+3,008
| +46% | +$462K | 0.18% | 119 |
|
|
2025
Q1 | $1.09M | Sell |
6,602
-992
| -13% | -$155K | 0.14% | 140 |
|
|
2024
Q4 | $1.1M | Sell |
7,594
-554
| -7% | -$85.8K | 0.14% | 145 |
|
|
2024
Q3 | $1.24M | Sell |
8,148
-248
| -3% | -$39.5K | 0.16% | 135 |
|
|
2024
Q2 | $1.23M | Buy |
8,396
+152
| +2% | +$22.6K | 0.18% | 130 |
|
|
2024
Q1 | $1.24M | Sell |
8,244
-1,764
| -18% | -$281K | 0.18% | 126 |
|
|
2023
Q4 | $1.57M | Sell |
10,008
-5,180
| -34% | -$794K | 0.22% | 116 |
|
|
2023
Q3 | $2.37M | Sell |
15,188
-1,983
| -12% | -$327K | 0.38% | 60 |
|
|
2023
Q2 | $2.84M | Buy |
17,171
+174
| +1% | +$28.1K | 0.45% | 47 |
|
|
2023
Q1 | $2.63M | Sell |
16,997
-967
| -5% | -$156K | 0.45% | 52 |
|
|
2022
Q4 | $3.17M | Buy |
17,964
+235
| +1% | +$40.6K | 0.57% | 38 |
|
|
2022
Q3 | $2.9M | Buy |
17,729
+283
| +2% | +$47.9K | 0.51% | 41 |
|
|
2022
Q2 | $3.1M | Buy |
17,446
+3,932
| +29% | +$701K | 0.56% | 37 |
|
|
2022
Q1 | $2.44M | Buy |
13,514
+1,786
| +15% | +$304K | 0.46% | 46 |
|
|
2021
Q4 | $2.01M | Sell |
11,728
-343
| -3% | -$56.2K | 0.45% | 53 |
|
|
2021
Q3 | $1.95M | Sell |
12,071
-2,190
| -15% | -$374K | 0.52% | 46 |
|
|
2021
Q2 | $2.35M | Buy |
14,261
+2,563
| +22% | +$424K | 0.73% | 31 |
|
|
2021
Q1 | $1.88M | Sell |
11,698
-819
| -7% | -$133K | 0.78% | 33 |
|
|
2020
Q4 | $1.97M | Buy |
12,517
+1,479
| +13% | +$218K | 0.9% | 33 |
|
|
2020
Q3 | $1.63M | Buy |
11,038
+1,287
| +13% | +$190K | 0.89% | 31 |
|
|
2020
Q2 | $1.37M | Buy |
9,751
+115
| +1% | +$16.8K | 0.86% | 35 |
|
|
2020
Q1 | $1.24M | Sell |
9,636
-4
| -0% | -$567 | 0.84% | 35 |
|
|
2019
Q4 | $1.41M | Buy |
9,640
+58
| +0.6% | +$7.87K | 0.82% | 35 |
|
|
2019
Q3 | $1.25M | Buy |
9,582
+111
| +1% | +$14.6K | 0.83% | 34 |
|
|
2019
Q2 | $1.32M | Sell |
9,471
-147
| -2% | -$20.3K | 0.91% | 30 |
|
|
2019
Q1 | $1.34M | Sell |
9,618
-373
| -4% | -$50K | 1% | 29 |
|
|
2018
Q4 | $1.29M | Buy |
9,991
+302
| +3% | +$42.1K | 0.95% | 27 |
|
|
2018
Q3 | $1.35M | Buy |
9,689
+4,592
| +90% | +$610K | 0.9% | 29 |
|
|
2018
Q2 | $619K | Sell |
5,097
-413
| -7% | -$51.5K | 0.45% | 59 |
|
|
2018
Q1 | $706K | Sell |
5,510
-2,198
| -29% | -$297K | 0.59% | 43 |
|
|
2017
Q4 | $1.08M | Buy |
7,708
+329
| +4% | +$45.8K | 0.83% | 29 |
|
|
2017
Q3 | $959K | Buy |
7,379
+744
| +11% | +$98.6K | 0.84% | 31 |
|
|
2017
Q2 | $878K | Buy |
6,635
+759
| +13% | +$96.8K | 0.87% | 27 |
|
|
2017
Q1 | $732K | Buy |
+5,876
| New | +$702K | 0.88% | 31 |
|
Other funds holding JNJ
VCM
VPM
Continuum Advisory's JNJ Position: Q1 2026 in Review
Continuum Advisory reduced its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, selling an estimated $362K and leaving 8,589 shares worth $2.1M. The position accounts for 0.2% of the portfolio, ranked #102.
Continuum Advisory first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.17M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Continuum Advisory held 8,589 shares of Johnson & Johnson worth $2.1M as of Q1 2026.
- Continuum Advisory sold 1,554 Johnson & Johnson shares in Q1 2026, an estimated $362K.
- Johnson & Johnson made up 0.2% of Continuum Advisory's portfolio in Q1 2026, its #102 holding.
- Continuum Advisory first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
- Continuum Advisory's Johnson & Johnson position peaked at $3.17M in Q4 2022.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.